Cancer Biology Faculty Candidate
- May 18, 2021
- 12:00 PM - 1:00 CST
Dept. of Cancer Biology
Lorelei Martin, firstname.lastname@example.org
- No cost
- Not open to the public.
- Add to calendar
*A first-in-class Polymerase Theta inhibitor (POLQi) selectively targets Homologous Recombination-Deficient Tumors*
Presenter: Jia Zhou, PhD
Instructor in Radiation Oncology
Dana-Farber Cancer Institute
Harvard Medical School
Interested in attending? Please contact Lorelei Martin, email@example.com, for the Zoom link.